Imperial College London

ProfessorLouiseDonnelly

Faculty of MedicineNational Heart & Lung Institute

Professor of Respiratory Cell Biology
 
 
 
//

Contact

 

+44 (0)20 7594 7895l.donnelly

 
 
//

Location

 

G227AGuy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Summary

Louise Donnelly is Professor of Respiratory Cell Biology, within the Section of Airway Disease at the NHLI. She obtained her BSc in Biochemistry from the University of Bath and subsequently a PhD in Biochemistry from the University of Cardiff. This was followed by a post-doctoral position in cell signaling at the Royal Postgraduate Medical School (now part of Imperial College London) prior to working at the NHLI.

Since 1995, Professor Donnelly has worked in the field of respiratory cell biology with a particular interest in the cellular profile in inflammatory lung diseases including asthma and COPD. Her research has focussed upon how inflammatory cells are altered in the disease state and the investigation of novel therapeutic strategies. To this end, she has established a number of human primary cell systems to investigate mechanisms of aberrant inflammation. She has published extensively and has presented both nationally and internationally as well as acting as an editor for  Current Respiratory Medicine Reviews.

Professor Donnelly is currently Director of the Respiratory Science BSc and is involved in respiratory teaching on  the undergraduate MBSS course. In 2009, Professor Donnelly received a Rector's Award for Research Supervision and in 2012 a Rector's Award for Pastoral Care.

Professor Donnelly has been a member of the British Association of Lung Research (BALR) committee for several years and is the current chair of the BALR.  She is currently a member of the British Lung Foundation Scientific Committee and the European Respiratory Society Evaluation Committee

Publications

Journals

Belchamber KBR, Thomas C, Dunne A, et al., Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function, International Journal of Copd, ISSN:1176-9106

Dai Y, Yeo SCM, Barnes P, et al., Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative, Frontiers in Pharmacology, ISSN:1663-9812

Wang Z, Singh R, Miller BE, et al., 2018, Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study, Thorax, Vol:73, ISSN:0040-6376, Pages:331-338

Yanagisawa S, Baker JR, Vuppusetty C, et al., 2018, The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure, Plos One, Vol:13, ISSN:1932-6203

Patents

, Administration of Resveratrol to Treat Inflammatory Respiratory Disorders, US, 09/694, 108

More Publications